Hedge fund Old Lane Partners and venture capital firm Mayfield Ventures may buy around 20% stake in leading boutique investment bank Avendus Advisors for a sum of Rs. 80 crores. This puts the valuation of the bank at around Rs. 400 crores. Avendus is expected to gross annual revenues of $12 mn in 2006-07. The organization has grown from 16 professionals to 40 in 2006.
Avendus was founded in 1999 by Ranu Vohra, Gaurav Deepak and Kaushal Aggarwal. They and employees of Avendus hold around 70% of the bank’s equity stake. Americorp, a Spanish institutional investor, holds 20% and the rest is held by Californian entrepreneur-investor Anil Godhwani. A minority stake earlier held by Infinity Venture, a venture capital fund, had been bought back by promoters around 2 years back.
Recently, Avendus has inducted two senior officials as vice presidents. Kishore Srinivasan, former joint GM and Head, Closely Monitored Assets (CMA) at ICICI Bank, joined Avendus as vice president and is now heading its corporate debt services. Also, Rajiv Shukla, former director, business development, at Pfizer, has joined Avendus as vice president, heading its life science vertical. Mr. Shukla is known to have played a leadership role on 5 acquisitions at Pfizer totaling $63 bn. Just a couple of days ago, Avendus was in the news for the exit of some of its high-profile employees, notably, Deepesh Garg, Assistant Vice-President, Consumer Products and Services Team, and Shiraz Bugwadia, Assistant Vice-President, Pharmaceuticals and Healthcare.
Avendus focuses on wealth management, institutional broking and debt solutions. It offers private equity syndication, mergers & acquisitions (M&A), and strategic advisory services to corporates and funds. Currently, it is in the process of expanding its operations abroad by opening offices in New York and Munich.
Read The Economic Times article.
Related Post: Key senior people exit Avendus Advisors to float boutique investment bank
Thursday, January 11, 2007
Avendus Advisors to divest 20% stake to Old Lane and Mayfield Ventures
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment